With over 10 years of clinical expertise, Dr. Muzaffar Latif Gill's work spans more than 50 studies, enhancing our understanding of chronic Hepatitis C treatment, including the use of Peg-Interferon and Ribavirin. His international publications have significantly impacted the management of Hepatitis C virus infection, especially genotype 3, and have advanced the field of Hepatology. As a leading gastroenterologist in Pakistan, Dr. Gill continues to conduct groundbreaking research in the pursuit of better treatments.